Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00291811
Status:
APPROVED_FOR_MARKETING
Last Update Posted:
2014-02-11
First Post:
2006-02-13
Brief Title:
Access Program for Use of AMD3100 to Increase Peripheral Blood Stem Cells for Transplantation in Patients Who Have Failed Standard Therapy Stem Cell Mobilization
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi